Tech Company Financing Transactions
Axikin Pharmaceuticals Funding Round
Sanderling Ventures and private investors participated in a $3 million funding round for Axikin Pharmaceuticals. The round was announced on 12/31/2010.
Transaction Overview
Company Name
Announced On
12/31/2010
Transaction Type
Venture Equity
Amount
$2,967,000
Round
Undisclosed
Investors
Sanderling Ventures (Peter McWilliams)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10835 Road To The Cure 250
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Not Recorded
Overview
Axikin Pharmaceuticals develops small molecule therapeutics for severe respiratory, inflammatory and autoimmune diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
President
Kevin Bacon
Browse more venture capital transactions:
Prev: 12/31/2010: Ingrain venture capital transaction
Next: 12/31/2010: Thuuz venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on funding rounds that are announced publicly. All VC database entries on this site are derived from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs